A pharmaceutical company has developed an insulin delivery system that allows diabetics to inhale the drug rather than having to take daily injections. At the annual meeting of the American Diabetes Association in Chicago, Inhale Therapeutic Systems, a drug delivery company, reported that results of major clinical trials of lung-delivered insulin have shown that inhaling it is just as effective in controlling blood sugar as injecting it.